Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 0 | 0 | 9,149 |
| Cost of Goods | N/A | N/A | N/A | N/A | 7,249 |
| Gross Profit | N/A | N/A | N/A | N/A | 1,900 |
| Operating Expenses | 490 | 768 | 837 | -32,893 | 3,714 |
| Operating Income | -490 | -768 | -837 | 2,043 | -1,565 |
| Interest Expense | 76 | 51 | 262 | -470 | 253 |
| Other Income | 0 | 0 | 0 | -1,833 | 1,858 |
| Pre-tax Income | -565 | -818 | -1,099 | 680 | 40 |
| Income Tax | N/A | N/A | N/A | N/A | -1 |
| Net Income Continuous | -565 | -818 | -1,099 | 665 | 41 |
| Net Income | $-565 | $-818 | $-1,099 | $665 | $41 |
| EPS Basic Total Ops | -899.91 | -1,349.87 | -1,709.83 | 60,293.98 | -1,079.89 |
| EPS Basic Continuous Ops | -867.88 | -1,298.45 | -1,748.35 | 54,550.24 | 703.56 |
| EPS Diluted Total Ops | -899.91 | -1,349.87 | -1,709.83 | 60,293.98 | -1,079.89 |
| EPS Diluted Continuous Ops | -867.88 | -1,298.45 | -1,748.35 | 54,550.24 | 703.56 |
| EBITDA(a) | $-454 | $-768 | $-837 | $31,838 | $-1,565 |